These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 19223299)

  • 1. Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection.
    Rodríguez-Baño J; Alcalá J; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
    J Antimicrob Chemother; 2009 Apr; 63(4):781-4. PubMed ID: 19223299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G; Costello M; Pitout JD
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
    Azap OK; Arslan H; Serefhanoğlu K; Colakoğlu S; Erdoğan H; Timurkaynak F; Senger SS
    Clin Microbiol Infect; 2010 Feb; 16(2):147-51. PubMed ID: 19689464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control.
    Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; Perea EJ; Pérez-Cano R; Hernández JR; Pascual A
    Clin Infect Dis; 2006 Jan; 42(1):37-45. PubMed ID: 16323089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTX-M type extended spectrum beta-lactamases in Escherichia coli isolates from community acquired upper urinary tract infections at a university in the European part of Turkey.
    Celik AD; Yulugkural Z; Kuloglu F; Eroglu C; Torol S; Vahaboğlu H; Akata F
    J Microbiol Immunol Infect; 2010 Apr; 43(2):163-7. PubMed ID: 20457435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting.
    Arpin C; Quentin C; Grobost F; Cambau E; Robert J; Dubois V; Coulange L; André C;
    J Antimicrob Chemother; 2009 Jun; 63(6):1205-14. PubMed ID: 19329798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women.
    Ho PL; Poon WW; Loke SL; Leung MS; Chow KH; Wong RC; Yip KS; Lai EL; Tsang KW;
    J Antimicrob Chemother; 2007 Jul; 60(1):140-4. PubMed ID: 17496058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.
    Rodríguez-Baño J; Picón E; Gijón P; Hernández JR; Ruíz M; Peña C; Almela M; Almirante B; Grill F; Colomina J; Giménez M; Oliver A; Horcajada JP; Navarro G; Coloma A; Pascual A;
    Clin Infect Dis; 2010 Jan; 50(1):40-8. PubMed ID: 19995215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
    Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
    J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of ESBL types in community acquired urinary Escherichia coli isolates by isoelectric focusing and polymerase chain reaction].
    Dağlar D; Ongüt G; Oğünç D; Ozhak Baysan B; Demirbakan H; Sepin Özen N; Gültekin M
    Mikrobiyol Bul; 2010 Jul; 44(3):367-74. PubMed ID: 21063986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of rectal carriage of extended-spectrum beta-lactamase-producing Escherichia coli among elderly people in community settings in China.
    Tian SF; Chen BY; Chu YZ; Wang S
    Can J Microbiol; 2008 Sep; 54(9):781-5. PubMed ID: 18772941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.
    Yumuk Z; Afacan G; Nicolas-Chanoine MH; Sotto A; Lavigne JP
    J Antimicrob Chemother; 2008 Aug; 62(2):284-8. PubMed ID: 18453527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology.
    Rodríguez-Baño J; López-Cerero L; Navarro MD; Díaz de Alba P; Pascual A
    J Antimicrob Chemother; 2008 Nov; 62(5):1142-9. PubMed ID: 18641033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of multiresistant Escherichia coli isolates from community-onset urinary tract infections in Cornwall, England.
    Woodford N; Kaufmann ME; Karisik E; Hartley JW
    J Antimicrob Chemother; 2007 Jan; 59(1):106-9. PubMed ID: 17090553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of strains producing extended-spectrum beta-lactamases and genotype distribution in China.
    Yu Y; Ji S; Chen Y; Zhou W; Wei Z; Li L; Ma Y
    J Infect; 2007 Jan; 54(1):53-7. PubMed ID: 16533535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTX-M-15 extended-spectrum (beta)-lactamase from Nigerian Klebsiella pneumoniae.
    Soge OO; Queenan AM; Ojo KK; Adeniyi BA; Roberts MC
    J Antimicrob Chemother; 2006 Jan; 57(1):24-30. PubMed ID: 16319181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of CTX-M-type beta-lactamases in isolates of Escherichia coli infecting hospital and community patients.
    Brigante G; Luzzaro F; Perilli M; Lombardi G; Colì A; Rossolini GM; Amicosante G; Toniolo A
    Int J Antimicrob Agents; 2005 Feb; 25(2):157-62. PubMed ID: 15664486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia.
    Severin JA; Mertaniasih NM; Kuntaman K; Lestari ES; Purwanta M; Lemmens-Den Toom N; Duerink DO; Hadi U; van Belkum A; Verbrugh HA; Goessens WH;
    J Antimicrob Chemother; 2010 Mar; 65(3):465-9. PubMed ID: 20053690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTX-M-producing Escherichia coli in a maternity ward: a likely community importation and evidence of mother-to-neonate transmission.
    Dubois V; De Barbeyrac B; Rogues AM; Arpin C; Coulange L; Andre C; M'zali F; Megraud F; Quentin C
    J Antimicrob Chemother; 2010 Jul; 65(7):1368-71. PubMed ID: 20466850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.